ArticleBMJ open2026

Efficacy of sequential denosumab after teriparatide for 6 months compared with denosumab monotherapy in reducing risk of osteoporotic fractures in patients with new fractures: a multicentre randomised controlled trial (STAND study) protocol.

Yue Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.